Back
Novartis AG Vs. Viking Therapeutics Industry Stock Comparison
Buy
67
NVS
Novartis AG
Last Price:
105.76
Seasonality Move:
1.38%
Sell
38
VKTX
Viking Therapeutics
Last Price:
52.01
Seasonality Move:
-3.44%
Buy
67
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVS] share price is $106.02. The Score for NVS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- NVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $52.10. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $106.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $52.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
NVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.65 | Buy |
| Relative Strength Index (14 RSI): | 66.63 | Buy |
| Chaikin Money Flow: | 752282 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101 - 104.96) | Buy |
| Bollinger Bands (100): | (96.3 - 104.16) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.62 | Sell |
| Relative Strength Index (14 RSI): | 31.38 | Sell |
| Chaikin Money Flow: | 45869 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.87 - 71.09) | Sell |
| Bollinger Bands (100): | (40.62 - 80.36) | Sell |
NVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.4 | Buy |
| 20-day SMA: | 103.17 | Buy |
| 50-day SMA: | 99.57 | Buy |
| 200-day SMA: | 99.61 | Buy |
| 8-day EMA: | 104.96 | Buy |
| 20-day EMA: | 103.38 | Buy |
| 50-day EMA: | 101.23 | Buy |
| 200-day EMA: | 99.4 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.97 | Sell |
| 20-day SMA: | 60.52 | Sell |
| 50-day SMA: | 67.71 | Sell |
| 200-day SMA: | 37.37 | Buy |
| 8-day EMA: | 55.23 | Sell |
| 20-day EMA: | 60.09 | Sell |
| 50-day EMA: | 63.57 | Sell |
| 200-day EMA: | 45.15 | Buy |
Novartis AG Earnings Growth & NVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.56 per share, and an increase next year of $0.80 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.
Novartis AG Technical Analysis
| May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||